<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: The risk of <z:e sem="disease" ids="C0007222" disease_type="Disease or Syndrome" abbrv="CVD">cardiovascular disease</z:e> in type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> is greater than is accounted for by conventional risk factors </plain></SENT>
<SENT sid="1" pm="."><plain>We investigated whether energy restriction or modest fat loss improved the <z:chebi fb="23" ids="18059">lipid</z:chebi> profile in <z:mp ids='MP_0001261'>obese</z:mp> subjects with and without type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> </plain></SENT>
<SENT sid="2" pm="."><plain>The relationship of site of <z:hpo ids='HP_0008887'>adipose tissue loss</z:hpo> to <z:chebi fb="23" ids="18059">lipid</z:chebi> changes was also examined </plain></SENT>
<SENT sid="3" pm="."><plain>RESEARCH DESIGN AND METHODS: <z:chebi fb="23" ids="18059">Lipid</z:chebi> levels were measured in 18 subjects with <z:mpath ids='MPATH_458'>normal</z:mpath> <z:chebi fb="105" ids="17234">glucose</z:chebi> tolerance (NGT) (n = 9, BMI = 31.5 +/- 0.8 [<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">SEM</z:e>] kg/m2) or type 2 <z:mp ids='MP_0002055'>diabetes</z:mp> (n = 9, BMI = 31.8 +/- 0.7) before and on the 4th (d4) and 28th (d28) days of a hypocaloric formula diet </plain></SENT>
<SENT sid="4" pm="."><plain>Body composition was assessed with dual energy X-ray absorptiometry on d0 and d28 </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Mean daily energy intake during the diet was 1,100 +/- 60 kcal (33% protein, 38% carbohydrate, and 29% fat) </plain></SENT>
<SENT sid="6" pm="."><plain>Mean <z:hpo ids='HP_0001824'>weight loss</z:hpo> was 6.2 +/- 0.4 kg </plain></SENT>
<SENT sid="7" pm="."><plain>Initial <z:chebi fb="23" ids="18059">lipid</z:chebi> profiles were similar in subjects with or without <z:mp ids='MP_0002055'>diabetes</z:mp>, and <z:mp ids='MP_0002055'>diabetes</z:mp> did not affect the responses </plain></SENT>
<SENT sid="8" pm="."><plain>Dietary intervention resulted in early (d4) and late (d28) changes </plain></SENT>
<SENT sid="9" pm="."><plain>Energy restriction (d4) reduced <z:chebi fb="0" ids="47773">VLDL cholesterol</z:chebi> and total <z:chebi fb="0" ids="17855">triglyceride</z:chebi> (TG) concentrations and increased <z:chebi fb="15" ids="39026">LDL</z:chebi> particle size </plain></SENT>
<SENT sid="10" pm="."><plain><z:chebi fb="15" ids="39026">LDL</z:chebi> TG, and <z:chebi fb="15" ids="39026">LDL</z:chebi> <z:chebi fb="0" ids="39015">apolipoprotein</z:chebi> B (apoB) concentrations </plain></SENT>
<SENT sid="11" pm="."><plain>Reduction in central abdominal fat (but not other body fat) was correlated with a less atherogenic <z:chebi fb="23" ids="18059">lipid</z:chebi> profile: delta abdominal fat versus delta <z:chebi fb="15" ids="39026">LDL</z:chebi> free cholesterol, r = 0.65, P = 0.006 and versus delta apoB, r = 0.64, P = 0.008 </plain></SENT>
<SENT sid="12" pm="."><plain>CONCLUSIONS: Even in <z:mp ids='MP_0001261'>obese</z:mp> subjects with an average <z:chebi fb="23" ids="18059">lipid</z:chebi> profile, modest <z:hpo ids='HP_0001824'>weight loss</z:hpo> reduces atherogenicity, independently of type 2 <z:mp ids='MP_0002055'>diabetes</z:mp>, and abdominal fat loss is specifically related to such improvements </plain></SENT>
</text></document>